Skip to main content
Genmab logo

Genmab — Investor Relations & Filings

Ticker · GMAB ISIN · DK0010272202 LEI · 529900MTJPDPE4MHJ122 CO Manufacturing
Open in API
Filings indexed 2,819 across all filing types
Latest filing 2023-06-20 Share Issue/Capital Cha…
Country DK Denmark
Listing CO GMAB

About Genmab

https://www.genmab.com/

Genmab is an international biotechnology company that specializes in the creation, development, and commercialization of differentiated antibody therapeutics. The company focuses on transforming the treatment of cancer and other serious diseases. By utilizing proprietary antibody technology platforms and scientific expertise, Genmab develops a pipeline of innovative medicines. Its activities span from discovery and research through clinical development to deliver novel therapies to patients.

Recent filings

Filing Released Lang Actions
Capital Increase in Genmab as a Result of Employee Warrant Exercise
Share Issue/Capital Change Classification · 1% confidence The document is a formal company announcement regarding a capital increase resulting from the exercise of employee warrants. It details the number of shares issued, the subscription prices, the impact on total share capital, and the regulatory compliance with the Danish Capital Markets Act. This falls squarely under the definition of a share issue or capital change announcement.
2023-06-20 English
6-K
Foreign Filer Report
2023-06-20 English
6-K
Foreign Filer Report
2023-06-08 English
6-K
Foreign Filer Report
2023-06-01 English
Director's Dealing 2023
Director's Dealing Classification · 1% confidence The document is titled 'Transactions with shares and linked securities in Genmab A/S made by managerial employees and their closely associated persons' and explicitly states it discloses data of transactions made by managerial employees in accordance with Article 19 of Regulation No. 596/2014 (Market Abuse Regulation). This type of filing specifically reports personal share transactions by company directors and executives (insider trades). This directly matches the definition for Director's Dealing (DIRS). Although it is a company announcement, the content is highly specific to insider trading disclosure, making DIRS a more precise classification than a general Regulatory Filing (RNS) or Report Publication Announcement (RPA).
2023-06-01 English
Transactions with shares and linked securities in Genmab A/S made by managerial employees and their closely associated persons
Director's Dealing Classification · 1% confidence The document is a formal notification of share transactions conducted by a person discharging managerial responsibilities (the CFO, Anthony Pagano). It explicitly references Article 19 of Regulation No. 596/2014 (Market Abuse Regulation), which mandates the disclosure of insider/director dealings. The content provides specific details of the transaction, including the instrument, price, volume, and date, which aligns perfectly with the definition of a Director's Dealing (DIRS) filing.
2023-06-01 English

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.